ArticleInfection and drug resistance2025
Seroprevalence and Clinical Insights of Ocular Herpesvirus Infections: A Cross-Sectional Study Evaluating ELISA as a Diagnostic Tool.
Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims and Objectives: Ocular infections caused by Methods: We conducted a cross-sectional study using enzyme-linked immunosorbent assay (ELISA) to detect antibodies against HSV and VZV in patients with ocular symptoms. Serological data were stratified into IgG and IgM positivity to differentiate past from active infections. Serological data were stratified into IgG (indicative of past infection) and IgM (suggestive of active infection) positivity to differentiate past from active infections. A total of 200 patients were enrolled, and demographic and clinical data were collected, including age, history of ocular surgery, and immunosuppressive therapy. Results: The overall seroprevalence for HSV was 14%, and for VZV, it was 9%. Age was a significant risk factor for both infections, with individuals over 50 years (mean age of 48.9 ± 13.8 years) showing increased seropositivity ( Conclusion and Recommendations: ELISA-based antibody detection proved effective in identifying both past and active HSV and VZV infections. The findings highlight age, ocular surgery, and immunosuppressive therapy as key risk factors for these infections. Given the diagnostic limitations of ELISA, future studies should incorporate molecular diagnostics for enhanced accuracy. These findings support the use of ELISA for screening high-risk populations, although adjunct molecular testing may improve diagnostic accuracy. Early serological screening in high-risk patients could aid in the timely detection and management of ocular herpesvirus infections.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.